Compare ELTX & OESX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ELTX | OESX |
|---|---|---|
| Founded | 2011 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Building Products |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 45.6M | 49.7M |
| IPO Year | 2014 | 2007 |
| Metric | ELTX | OESX |
|---|---|---|
| Price | $1.52 | $12.75 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 2 |
| Target Price | $13.00 | ★ $36.00 |
| AVG Volume (30 Days) | ★ 305.0K | 37.2K |
| Earning Date | 11-05-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 39.29 | N/A |
| EPS | N/A | ★ 0.27 |
| Revenue | $2,301,000.00 | ★ $86,306,000.00 |
| Revenue This Year | N/A | $17.95 |
| Revenue Next Year | N/A | $10.38 |
| P/E Ratio | ★ N/A | $48.43 |
| Revenue Growth | N/A | ★ 8.26 |
| 52 Week Low | $1.25 | $8.58 |
| 52 Week High | $16.00 | $31.65 |
| Indicator | ELTX | OESX |
|---|---|---|
| Relative Strength Index (RSI) | 40.97 | 27.08 |
| Support Level | $1.35 | $8.98 |
| Resistance Level | $1.98 | $21.13 |
| Average True Range (ATR) | 0.19 | 1.60 |
| MACD | 0.01 | -0.46 |
| Stochastic Oscillator | 42.19 | 14.19 |
Elicio Therapeutics Inc is a clinical-stage biotechnology company advancing novel immunotherapies for the treatment of cancer, including mKRAS-positive pancreatic cancer, colorectal cancer (CRC), lung cancer, and other mKRAS-positive cancers. The Company focuses on developing effective, off-the-shelf immunotherapies using its proprietary Amphiphile (AMP) technology, which aims to enhance the education, activation, and amplification of cancer-specific T cells to promote durable cancer immunosurveillance. Its clinical pipeline includes ELI-002 7P, a lymph node-targeted cancer immunotherapy currently being evaluated in a Phase 2 study for mKRAS pancreatic ductal adenocarcinoma (PDAC), a common form of pancreatic cancer.
Orion Energy Systems Inc provide light emitting diode (LED) lighting systems, wireless Internet of Things (IoT) enabled control solutions, commercial and industrial electric vehicle charging infrastructure solutions and lighting and electrical maintenance services. It help its customers achieve their sustainability, energy savings and carbon footprint reduction goals through technology and exceptional service. It sell its products and services into many vertical markets within the broader commercial and industrial market segment. Primary verticals include box retail, manufacturing, warehousing/logistics, federal and municipal government, healthcare and schools. It has three segments Lighting, Maintenance, and EV segment. It generates majority of revenue from Lighting segment.